VTVT - vTvセラピュ―ティクス (vTv Therapeutics Inc.)

VTVTのニュース

   The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs  2021/03/19 11:46:46 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Vericel Corporation (NASDAQ: VCEL ) Vincerx Pharma, Inc. (NASDAQ: VINC ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 18) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) (issued a corporate update) Galecto, Inc. (NASDAQ: GLTO ) Voyager Therapeutics, Inc. (NASDAQ: VYGR ) Stocks In Focus Sarepta Presents Positive Data For Gene Therapy to Treat Limb-gridle Muscular Dystrophy Sarepta Therapeutics, Inc. (NASDAQ: SRPT ) announced new results from the ongoing study of SRP-9003, its investigational gene therapy for limb-girdle muscular dystrophy Type 2E, showing sustained protein expression in muscle tissue.
   6 Stocks Moving In Thursday's After-Hours Session  2021/03/18 16:40:00 Benzinga
Gainers VTv Therapeutics (NASDAQ: VTVT) shares are trading higher after the company announced the initiation of a mechanistic study exploring the effects of …
   vTv Therapeutics may delivered a positive earnings surprise Stock market Insights & financial analysis  2021/02/18 14:26:00 Stock Market Daily
vTv Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Penny Stocks Are Soaring In The Pre-Market  2021/02/04 14:11:10 Zero Hedge
Penny Stocks Are Soaring In The Pre-Market It appears we were right when we suggested last week that after the Reddit-Raiders were done with squeezing shorts, they would transition to penny-stock-pumping. What's after the short squeeze slaughter: the pennystock pump? — zerohedge (@zerohedge) January 30, 2021 As Micro-Cap stocks have surged in recent days… Today's advance in the pre-market is dominated by a handful of biotech penny-stocks. Anavex Life Sciences, VTv Therapeutics and Cassava Sciences, all drug developers racing to come up with treatments for Alzheimer’s disease, were among the top performers. Along with Cassava, biotechs picking up steam on Reddit also included Covid-19 plays such as Tonix Pharmaceuticals and Atossa Therapeutics. Their shares traded in the millions during the early morning session. Additionally, Bloomberg notes that companies with low float compared to shares outstanding are soaring , such as Profire Energy +57% and DavidsTea +24%. So, will Penny-Stocks be the next 'GameStop'?
   vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually  2021/01/06 21:30:00 GlobeNewswire
HIGH POINT, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the…
   Penny Stocks Are Soaring In The Pre-Market  2021/02/04 14:11:10 Zero Hedge
Penny Stocks Are Soaring In The Pre-Market It appears we were right when we suggested last week that after the Reddit-Raiders were done with squeezing shorts, they would transition to penny-stock-pumping. What's after the short squeeze slaughter: the pennystock pump? — zerohedge (@zerohedge) January 30, 2021 As Micro-Cap stocks have surged in recent days… Today's advance in the pre-market is dominated by a handful of biotech penny-stocks. Anavex Life Sciences, VTv Therapeutics and Cassava Sciences, all drug developers racing to come up with treatments for Alzheimer’s disease, were among the top performers. Along with Cassava, biotechs picking up steam on Reddit also included Covid-19 plays such as Tonix Pharmaceuticals and Atossa Therapeutics. Their shares traded in the millions during the early morning session. Additionally, Bloomberg notes that companies with low float compared to shares outstanding are soaring , such as Profire Energy +57% and DavidsTea +24%. So, will Penny-Stocks be the next 'GameStop'?
   vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually  2021/01/06 21:30:00 GlobeNewswire
HIGH POINT, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the…
   Aditum Bio Announces Formation of Third Company, Anteris Bio  2020/12/15 14:05:00 Benzinga
OAKLAND, Calif. , Dec. 15, 2020 /PRNewswire/ -- Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark Fishman , today announced the formation of Anteris Bio, a portfolio company developing a new therapy for the treatment of renal disease. Anteris Bio is being formed following the successful in-licensing of ANT-401 from vTv Therapeutics (NASDAQ: VTVT ). Anteris Bio is the third independent company launched by Aditum Bio, whose mission is to give large patient populations access to medicines which otherwise may not be developed. To speed these drugs to market, Aditum Bio fosters an incubator model, focusing on the translational phase of drug development. The "spin out" model enables a nimble, start-up culture with its own dedicated team of managers. "We are excited to announce the formation of Anteris Bio, with its focus on renal disease. Unmet … Full story available on Benzinga.
   Ronald O. Perelman Acquires 625,000 Shares of vTv Therapeutics Inc. (NASDAQ:VTVT) Stock  2020/12/12 10:46:42 Watchlist News
vTv Therapeutics Inc. (NASDAQ:VTVT) major shareholder Ronald O. Perelman bought 625,000 shares of vTv Therapeutics stock in a transaction on Thursday, December 10th. The shares were acquired at an average price of $1.60 per share, for a total transaction of $1,000,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which […]
   5 Top Stock Gainers for Friday: Disney, FAT Brands  2020/12/11 17:46:16 The Street
Walt Disney, vTv Therapeutics, Nanthealth, Solid Biosciences and FAT Brands are five of the top stock gainers for Friday.
   Aditum Bio Announces Formation of Third Company, Anteris Bio  2020/12/15 14:05:00 Benzinga
OAKLAND, Calif. , Dec. 15, 2020 /PRNewswire/ -- Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark Fishman , today announced the formation of Anteris Bio, a portfolio company developing a new therapy for the treatment of renal disease. Anteris Bio is being formed following the successful in-licensing of ANT-401 from vTv Therapeutics (NASDAQ: VTVT ). Anteris Bio is the third independent company launched by Aditum Bio, whose mission is to give large patient populations access to medicines which otherwise may not be developed. To speed these drugs to market, Aditum Bio fosters an incubator model, focusing on the translational phase of drug development. The "spin out" model enables a nimble, start-up culture with its own dedicated team of managers. "We are excited to announce the formation of Anteris Bio, with its focus on renal disease. Unmet … Full story available on Benzinga.
   Ronald O. Perelman Acquires 625,000 Shares of vTv Therapeutics Inc. (NASDAQ:VTVT) Stock  2020/12/12 10:46:42 Watchlist News
vTv Therapeutics Inc. (NASDAQ:VTVT) major shareholder Ronald O. Perelman bought 625,000 shares of vTv Therapeutics stock in a transaction on Thursday, December 10th. The shares were acquired at an average price of $1.60 per share, for a total transaction of $1,000,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which […]
   5 Top Stock Gainers for Friday: Disney, FAT Brands  2020/12/11 17:46:16 The Street
Walt Disney, vTv Therapeutics, Nanthealth, Solid Biosciences and FAT Brands are five of the top stock gainers for Friday.
   Disney, FAT Brands: 5 Top Stock Gainers for Friday  2020/12/11 17:46:00 Yahoo Finance
Walt Disney, vTv Therapeutics, Nanthealth, Solid Biosciences and FAT Brands are five of the top stock gainers for Friday.
   VTVT Stock: vTv Therapeutics Gets Picked Up By MacAndrews & Forbes  2020/12/11 13:35:33 CNA Finance
VTVT stock is screaming for the top, trading in multiples after an SEC Filing showed that MacAndrews & Forbes bought shares.

calendar